Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Baylor Scott & White Research Institute enrolls first patients in NIH ACTIV-3 clinical trial

Baylor Scott & White Research Institute enrolls first patients in NIH ACTIV-3 clinical trial

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

ACTG initiates novel clinical trial to evaluate multiple therapeutics for COVID-19

ACTG initiates novel clinical trial to evaluate multiple therapeutics for COVID-19

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

Picomolar inhibitors to SARS-CoV-2 proteins

Picomolar inhibitors to SARS-CoV-2 proteins

Clinical trial to test safety, efficacy of antibody treatment in hospitalized COVID-19 patients

Clinical trial to test safety, efficacy of antibody treatment in hospitalized COVID-19 patients

Scientists develop human lung organoids to study SARS-CoV-2 infection

Scientists develop human lung organoids to study SARS-CoV-2 infection

DSI appoints new head of project management

DSI appoints new head of project management

Basigin/CD147 discarded as an accessory SARS-CoV-2 binding receptor

Basigin/CD147 discarded as an accessory SARS-CoV-2 binding receptor

MP Biomedicals and A*STAR jointly develop rapid antibody test kit for COVID-19

MP Biomedicals and A*STAR jointly develop rapid antibody test kit for COVID-19

NIH establishes a unified clinical trial network for testing COVID-19 vaccines

NIH establishes a unified clinical trial network for testing COVID-19 vaccines

New technology can rapidly disrupt existing biofilms that account for chronic diseases

New technology can rapidly disrupt existing biofilms that account for chronic diseases

Study sheds new light on protein movement

Study sheds new light on protein movement

Repurposed drug for acute lung injury in COVID-19

Repurposed drug for acute lung injury in COVID-19

Protein profile in serum reflects COVID-19 severity

Protein profile in serum reflects COVID-19 severity

Hormone involved in obesity could increase the risk for sepsis infection

Hormone involved in obesity could increase the risk for sepsis infection

New therapy provides relief in patients with chronic low back pain

New therapy provides relief in patients with chronic low back pain

NJIT researchers develop new efficient method for targeted protein analysis

NJIT researchers develop new efficient method for targeted protein analysis

An improved tetravalent antibody blocks SARS-CoV-2 infection

An improved tetravalent antibody blocks SARS-CoV-2 infection

Antibody cocktail with potential to treat COVID-19 identified

Antibody cocktail with potential to treat COVID-19 identified